Plasma levels of tumour necrosis factor‐α and adiponectin can differentiate patients with psoriatic arthritis from those with psoriasis

Johnson, C. M.Fitch, K.Merola, J. F.Han, J.Qureshi, A. A.Li, W.-Q.2020-09-112020-09-112019-08Johnson, C. M., Fitch, K., Merola, J. F., Han, J., Qureshi, A. A., & Li, W.-Q. (2019). Plasma levels of tumour necrosis factor-α and adiponectin can differentiate patients with psoriatic arthritis from those with psoriasis. British Journal of Dermatology, 181(2), 379–380. https://doi.org/10.1111/bjd.17700https://hdl.handle.net/1805/23797enPublisher Policypsoriatic arthritispsoriasisbiomarker plasma levelPlasma levels of tumour necrosis factor‐α and adiponectin can differentiate patients with psoriatic arthritis from those with psoriasisArticle